ARHGAP33
Basic information
Region (hg38): 19:35774532-35788822
Previous symbols: [ "SNX26" ]
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARHGAP33 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 105 | 108 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 105 | 6 | 4 |
Variants in ARHGAP33
This is a list of pathogenic ClinVar variants found in the ARHGAP33 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-35777684-T-A | not specified | Uncertain significance (Sep 30, 2024) | ||
19-35777732-C-G | not specified | Uncertain significance (Nov 24, 2024) | ||
19-35778304-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
19-35778307-C-T | not specified | Uncertain significance (Dec 04, 2024) | ||
19-35778343-G-T | not specified | Uncertain significance (May 13, 2024) | ||
19-35778467-C-T | not specified | Uncertain significance (Dec 12, 2024) | ||
19-35778468-G-A | not specified | Uncertain significance (Aug 20, 2024) | ||
19-35778504-G-A | not specified | Uncertain significance (Feb 25, 2025) | ||
19-35778533-A-C | not specified | Uncertain significance (Nov 08, 2024) | ||
19-35778541-C-T | Benign (Apr 10, 2018) | |||
19-35779086-A-G | not specified | Uncertain significance (Dec 16, 2023) | ||
19-35780230-G-A | not specified | Uncertain significance (Aug 15, 2023) | ||
19-35780296-G-A | not specified | Uncertain significance (Jun 26, 2024) | ||
19-35780431-T-C | not specified | Uncertain significance (Aug 21, 2024) | ||
19-35780603-T-C | not specified | Uncertain significance (Oct 27, 2023) | ||
19-35780634-C-A | not specified | Uncertain significance (Oct 14, 2023) | ||
19-35780637-G-T | not specified | Uncertain significance (Jan 17, 2024) | ||
19-35780750-C-T | Likely benign (Dec 04, 2017) | |||
19-35780762-G-A | not specified | Uncertain significance (Mar 27, 2023) | ||
19-35780770-C-T | Likely benign (Sep 01, 2022) | |||
19-35780772-C-G | not specified | Uncertain significance (Nov 15, 2021) | ||
19-35780781-T-G | not specified | Uncertain significance (Mar 11, 2022) | ||
19-35780821-T-C | not specified | Likely benign (Sep 19, 2016) | ||
19-35780929-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
19-35780935-G-A | not specified | Uncertain significance (Jan 25, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARHGAP33 | protein_coding | protein_coding | ENST00000314737 | 21 | 14291 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0286 | 0.971 | 125701 | 0 | 46 | 125747 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.80 | 576 | 711 | 0.810 | 0.0000468 | 7016 |
Missense in Polyphen | 171 | 193.49 | 0.88375 | 2036 | ||
Synonymous | -0.276 | 310 | 304 | 1.02 | 0.0000198 | 2532 |
Loss of Function | 5.03 | 14 | 53.9 | 0.260 | 0.00000310 | 529 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000589 | 0.000565 |
Ashkenazi Jewish | 0.0000995 | 0.0000992 |
East Asian | 0.000170 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000173 | 0.000167 |
Middle Eastern | 0.000170 | 0.000163 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000497 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in several stages of intracellular trafficking. Could play an important role in the regulation of glucose transport by insulin. May act as a downstream effector of RHOQ/TC10 in the regulation of insulin-stimulated glucose transport (By similarity). {ECO:0000250}.;
- Pathway
- Insulin Signaling;Signal Transduction;Rho GTPase cycle;Signaling by Rho GTPases
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.678
- rvis_EVS
- -1.46
- rvis_percentile_EVS
- 3.86
Haploinsufficiency Scores
- pHI
- 0.402
- hipred
- Y
- hipred_score
- 0.595
- ghis
- 0.671
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Arhgap33
- Phenotype
- embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); pigmentation phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- small GTPase mediated signal transduction;response to toxic substance;protein transport;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction;regulation of dendritic spine morphogenesis
- Cellular component
- cytoplasm;cytosol;plasma membrane;protein-containing complex;dendritic spine
- Molecular function
- GTPase activator activity;protein binding;protein kinase binding;phosphatidylinositol binding